The associations of polymorphism C3435T multidrug resistance gene (MDR1) and regimen of inhaled glucocorticosteroid therapy in bronchial asthma (BA) patients

Z. Mironova, V. Trofimov, E. Iantchina, M. Simakova, M. Dubina (St. Petersburg, Russian Federation)

Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Session: Recent advances in the treatment and pathogenesis of asthma
Session type: Thematic Poster Session
Number: 3618
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Z. Mironova, V. Trofimov, E. Iantchina, M. Simakova, M. Dubina (St. Petersburg, Russian Federation). The associations of polymorphism C3435T multidrug resistance gene (MDR1) and regimen of inhaled glucocorticosteroid therapy in bronchial asthma (BA) patients. Eur Respir J 2008; 32: Suppl. 52, 3618

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Allele variants of C3435T multidrug resistance gene (MDR1), R130Q interleukin 13 (IL13) gene, 590C/T IL4 – Markers of steroid dependent bronchial asthma (BA) risk
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010


Polymorphisms of MDR1, ADRB2 and IL13 genes are markers of therapy-resistant bronchial asthma (BA) in Russian patients
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012


Association of C3435T polymorphism of MDR1 gene and T1808A polymorphism of NR3C1 gene with bronchial obstruction in severe asthmatics and COPD patients
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010


Polymorphism of multidrug resistance gene (MDR1), interleukin 4 (IL4), IL13 genes in asthmatic patients and patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008

ADRB2R gene polymorphism (pol.) associated with the severity of cystic fibrosis(CF) and the effectiveness of the use of inhaled bronchodilator
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010

E-cadherin gene polymorphisms in asthma patients using inhaled corticosteroids
Source: Eur Respir J 2011; 38: 1044-1052
Year: 2011



Effects of β2 agonists on mucociliary clearance (MCC) in patients with asthma - association to polymorphisms of the β2-adrenoceptor
Source: Eur Respir J 2003; 22: Suppl. 45, 478s
Year: 2003

Lack of effect of promoter, coding and 3‘ polymorphisms of the β2-adrenergic receptor (ADRB2) on the clinical response to salmeterol alone or with fluticasone propionate in subjects with asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008

Glucocorticosteroid receptor (GCR) gene isoforms expression in bronchial asthma (BA) patients
Source: Annual Congress 2011 - Asthma: a heterogeneous disease
Year: 2011


The associations between an IL-2 gene polymorphism and smoking in patients with recurrent pulmonary tuberculosis (RTB)
Source: International Congress 2018 – Novel findings in biomarkers of tobacco use, exposure, hazards and genetics
Year: 2018

The influence of polymorphisms of the β2- adrenoceptor (AR) gene and the β2-AR upstream peptide (BUP) on bronchoprotective tolerance development in asthmatic patients
Source: Eur Respir J 2001; 18: Suppl. 33, 515s
Year: 2001

Clustering of patients with bronchial asthma with regard to the genotypes for Bcl1 polymorphism in the glucocorticoid receptor gene
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017

E-cadherin (CDH-1) polymorphisms associate with airway remodeling, inflammation and FEV1 decline in asthma patients using inhaled corticosteroids (ICS)
Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases
Year: 2010

ADRB2 Gly16Arg polymorphism, asthma control and lung function decline
Source: Eur Respir J 2011; 38: 1029-1035
Year: 2011



Relationship of interleukin 10 1082 G/A gene polymorphism with the duration of nephrotoxic onset due to anti tuberculosis drugs in multi drug resistant tuberculosis patients
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019


Airway inflammation in CF patients with a 1237A polymorphism in the Alpha-1PI gene
Source: Eur Respir J 2001; 18: Suppl. 33, 1s
Year: 2001

LATE-BREAKING ABSTRACT: GLCCI1 rs37972 gene‘s polymorphism correlation with response to oral glucocorticosteroids treatment in severe asthmatics from the BIOAIR cohort
Source: Annual Congress 2012 - Gene-environment treatment and asthma
Year: 2012


Pharmacogenetic markers of steroid dependent bronchial asthma (BA) control
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020

Effects of Arg16Gly polymorphism in ADRB2 gene on responses to salmeterol or montelukast added to inhaled corticosteroids in Japanese asthmatic subjects
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012